Benzinga | Aug 4, 2020 07:23AM EDT

Mizuho Maintains Neutral on Neurocrine Biosciences, Raises Price Target to $132

Mizuho maintains Neurocrine Biosciences (NASDAQ:NBIX) with a Neutral and raises the price target from $127 to $132.